BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15686931)

  • 21. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Vullo D; Supuran CT
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
    Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT
    J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.
    Koz Ö; Ekinci D; Perrone A; Piacente S; Alankuş-Çalişkan Ö; Bedir E; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):412-7. PubMed ID: 22299585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet.
    Rusconi S; Innocenti A; Vullo D; Mastrolorenzo A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5763-7. PubMed ID: 15501037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates.
    Winum JY; Innocenti A; Gagnard V; Montero JL; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1683-6. PubMed ID: 15745821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extremo-α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides.
    Vullo D; De Luca V; Scozzafava A; Carginale V; Rossi M; Supuran CT; Capasso C
    Bioorg Med Chem; 2013 Aug; 21(15):4521-5. PubMed ID: 23777827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
    Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.